{
    "data": [
        {
            "id": "4402655",
            "title": "Innoviz Technologies to reduce workforce by 9%",
            "description": "<html><body><ul> <li>Innoviz Technologies (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/INVZ\" title=\"Innoviz Technologies Ltd.\">INVZ</a></span>) said it will reduce its <a href=\"https://seekingalpha.com/pr/19990369-innoviz-announces-optimization-of-operations-to-accelerate-path-to-profitability\" rel=\"noopener\" target=\"_blank\" title=\"workforce\">workforce</a> by ~9% as it looks to shift focus away from segments where \"development efforts have reached maturity.\"</li> <li>The firm said it expects the realignment to deliver cost savings of ~$12 million in<span class=\"paywall-full-content invisible\"> 2025.</span> </li> <li class=\"paywall-full-content invisible\">The company also expects to reduce its 2025 planned cash outlays by ~ $12 million on an annualized basis.</li> <li class=\"paywall-full-content invisible\">The cash savings are set to begin in the first quarter of 2025, with run rate savings expected to be reached by the end of the second quarter of 2025.</li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402655-innoviz-technologies-to-reduce-workforce-by-9",
            "pub_date": "2025-02-04 16:32:32",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402663",
            "title": "Herc raises dividend by 5.3% to $0.70",
            "description": "<html><body><ul>\n<li>Herc (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/HRI\" title=\"Herc Holdings Inc.\">HRI</a></span>) declares <a href=\"https://seekingalpha.com/pr/19990542-herc-holdings-inc-increases-quarterly-dividend-by-5-percent-to-0_70-per-share\" target=\"_blank\">$0.70/share quarterly dividend</a>, <font color=\"green\">5.3% increase</font> from prior dividend of $0.665.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/HRI/dividends/yield?source=news_bullet\">Forward yield</a> 1.42%</li>\n<li>Payable March 4; for shareholders of record Feb. 18; ex-div Feb. 18.</li>\n<li><a href=\"https://seekingalpha.com/symbol/HRI/dividends?source=news_bullet\">See HRI Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402663-herc-raises-dividend-by-53-to-070",
            "pub_date": "2025-02-04 16:34:00",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402612",
            "title": "Pfizer's 2025 guidance falls short of expectations",
            "description": "<html><body><ul> <li>Although Pfizer (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a></span>) reiterated 2025 financial guidance issued in December, the midpoints of the ranges for revenue and EPS are below consensus figures. </li> <li>The pharmaceutical giant is projecting revenue of $61B-$64B (midpoint $62.5B) this year. Consensus is $63B. EPS is estimated at $2.80-$3.00 (midpoint $2.90). Consensus is $2.93. </li> <li class=\"paywall-full-content invisible\">In Q4, Pfizer <a href=\"https://seekingalpha.com/news/4402570-pfizer-non-gaap-eps-of-0_63-beats-by-0_17-revenue-of-17_8b-beats-by-540m\" target=\"_self\" title=\"beat\">beat</a> on both the top and bottom lines.</li> <li class=\"paywall-full-content invisible\">In the quarter, Pfizer saw its biggest revenue gains, percentage-wise, in primary care and oncology, which both saw 27% year-over-year growth. Eliquis (apixaban), which the drugmaker markets with Bristol-Myers Squibb (<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a>), remained its top-selling drug, with ~$1.8B in revenue, a 14% increase compared to Q4 2023.</li> <li class=\"paywall-full-content invisible\">Vyndaqel and Vyndamax (tafamidis) saw the biggest year-over-year percentage gain in revenue, rising 61% to ~$1.5B.</li> <li class=\"paywall-full-content invisible\">The company noted it is on schedule to achieve ~$4.5B in cost savings by the end of the year as part of an ongoing cost realignment program. </li> </ul> </body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1689040811/image_1689040811.jpg",
            "link": "https://seekingalpha.com/news/4402612-pfizer-2025-guidance-falls-short-expectations",
            "pub_date": "2025-02-04 16:27:30",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402650",
            "title": "VICI Properties announces new $2.5B unsecured credit facility",
            "description": "<html><body><p dir=\"ltr\">VICI Properties (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/VICI\" title=\"VICI Properties Inc.\">VICI</a></span>) <a href=\"https://seekingalpha.com/pr/19990342-vici-properties-inc-announces-new-2_5-billion-unsecured-credit-facility\" rel=\"noopener\" target=\"_blank\" title=\"announced\">announced</a> on Tuesday the effectiveness of its new $2.5B multicurrency unsecured revolving credit facility that replaced its existing, and now terminated, unsecured revolving credit facility of the same size.</p> <p dir=\"ltr\">The revolving credit facility was substantially oversubscribed with<span class=\"paywall-full-content invisible\"> strong support from 15 financial institutions.</span></p> <p class=\"paywall-full-content invisible\" dir=\"ltr\">The revolving credit facility matures on February 3, 2029, and can be extended for two successive six-month terms or one twelve-month term. </p> <p class=\"paywall-full-content invisible\" dir=\"ltr\">Based on a pricing grid and the company’s current credit ratings and leverage ratios, the revolving credit facility currently bears interest at a rate of 85 basis points over the SOFR rate or, in the case of borrowings in a foreign currency, the corresponding index rate for such currency. </p> <p class=\"paywall-full-content invisible\" dir=\"ltr\">In addition, based on the company’s current credit ratings and leverage ratios, the revolving credit facility requires the payment of a facility fee of 20.0 basis points of total commitments. </p> <p class=\"paywall-full-content invisible\" dir=\"ltr\">The company has an option to increase the revolving credit facility by up to $1B, to the extent that any one or more lenders agree to provide such additional credit extensions.</p> <p class=\"paywall-full-content invisible\"> </p> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402650-vici-properties-announces-new-2_5b-unsecured-credit-facility",
            "pub_date": "2025-02-04 16:29:35",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402653",
            "title": "KKR & Co. declares $0.175 dividend",
            "description": "<html><body><ul> <li>KKR &amp; Co. (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/KKR\" title=\"KKR &amp; Co. Inc.\">KKR</a></span>) declared <a href=\"https://ir.kkr.com/media/document/303ebb79-89b5-4026-8422-130803394f8d/assets/KKR%20Q424%20Earnings%20Release.pdf?disposition=inline\" rel=\"nofollow\" target=\"_blank\">$0.175/share quarterly dividend</a>, in line with previous.</li> <li> <a href=\"https://seekingalpha.com/symbol/KKR/dividends/yield?source=news_bullet\">Forward yield</a> 0.43%</li> <li>Payable Feb. 28; for shareholders of record Feb. 14; ex-div Feb. 14.</li> <li>Beginning with the dividend to be announced with the results of the quarter<span class=\"paywall-full-content invisible\"> ending March 31, 2025, KKR intends to increase its regular annualized dividend per share of common stock from $0.70 to $0.74.</span> </li> <li class=\"paywall-full-content invisible\"><a href=\"https://seekingalpha.com/symbol/KKR/dividends?source=news_bullet\">See KKR Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402653-kkr-and-co-declares-0_175-dividend",
            "pub_date": "2025-02-04 16:24:19",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402654",
            "title": "Comstock subsidiary approved for $152M allocation for Oklahoma qualified private activity bonds",
            "description": "<html><body><div><ul> <li>Comstock (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/LODE\" title=\"Comstock Inc.\">LODE</a></span>) announced that its subsidiary, Comstock Fuels, was approved by the Oklahoma State Treasurer’s Office to issue up to $152M in qualified private activity bonds.</li> <li>This overall approval by the Oklahoma State Treasurer’s Office comes under the Oklahoma Private<span class=\"paywall-full-content invisible\"> Activity Bond Allocation Act and would consist of allocations from the Oklahoma Economic Development Pool, the Oklahoma Exempt Facilities Pool, and the Oklahoma Carryforward Pool.</span> </li> <li class=\"paywall-full-content invisible\">LODE shares rise 5.5% premarket on Tuesday.</li> <li class=\"paywall-full-content invisible\">Source: <a href=\"https://seekingalpha.com/pr/19990075-comstock-fuels-approved-for-152-million-allocation-for-oklahoma-qualified-private-activity\">Press release</a> </li> </ul></div> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402654-comstock-subsidiary-approved-for-152m-allocation-for-oklahoma-qualified-private-activity-bonds",
            "pub_date": "2025-02-04 16:25:26",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402640",
            "title": "McKesson to take 80% interest in PRISM Vision for about $850M",
            "description": "<html><body><p class=\"MsoNormal\">McKesson (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/MCK\" title=\"McKesson Corporation\">MCK</a></span>) has agreed to acquire an 80% controlling interest in PRISM Vision Holdings, an ophthalmology and retina management services provider, from Quad-C for about $850M.</p> <p class=\"MsoNormal\">PRISM Vision physicians will continue to retain a 20% interest in PRISM Vision. The transaction is<span class=\"paywall-full-content invisible\"> subject to customary closing conditions, including necessary regulatory clearances.</span></p> <p class=\"MsoNormal paywall-full-content invisible\">This transaction will enable McKesson to develop a leading retinal and ophthalmology platform. PRISM affiliated practices include more than 180 providers, 91 office locations and seven ambulatory surgery centers</p> <p class=\"MsoNormal paywall-full-content invisible\">Following completion of the transaction, PRISM Vision will be consolidated within McKesson’s U.S. Pharmaceutical segment.</p> <p class=\"MsoNormal paywall-full-content invisible\">Upon closing, PRISM Vision is expected to be around $0.20 to $0.30 accretive to McKesson’s adjusted earnings per diluted share in the first 12 months, and $0.65 to $0.75 accretive by the end of the third year following close.</p> <p class=\"MsoNormal paywall-full-content invisible\">“The acquisition of PRISM Vision will allow McKesson to build on our leadership in community practice and specialty solutions, while building a platform to serve the high-growth area of retina and ophthalmology,” said Brian Tyler, chief executive officer of McKesson.</p> <p class=\"paywall-full-content invisible\">Source: <a href=\"https://seekingalpha.com/pr/19990372-mckesson-advances-specialty-leadership-signs-agreement-to-acquire-controlling-interest-in\">Press Release</a></p> </body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1299649026/image_1299649026.jpg",
            "link": "https://seekingalpha.com/news/4402640-mckesson-to-take-80-interest-in-prism-vision-for-about-850m",
            "pub_date": "2025-02-04 16:18:01",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402652",
            "title": "Oaktree Specialty Lending declares $0.40 dividend",
            "description": "<html><body><ul>\n<li>Oaktree Specialty Lending (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/OCSL\" title=\"Oaktree Specialty Lending Corporation\">OCSL</a></span>) declared <a href=\"https://seekingalpha.com/pr/19990039-oaktree-specialty-lending-corporation-announces-first-fiscal-quarter-2025-financial-results\" target=\"_blank\">$0.40/share quarterly dividend</a>.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/OCSL/dividends/yield?source=news_bullet\">Forward yield</a> 10.03%</li>\n<li>The Board of Directors also declared a supplemental distribution of $0.07 per share.</li>\n<li>Payable March 31; for shareholders of record March 17; ex-div March 17.</li>\n<li>The company had <a href=\"https://seekingalpha.com/news/4306720-oaktree-specialty-lending-declares-055-dividend\">declared</a> of $0.55 per share quarterly cash distribution in November 2024.</li>\n<li><a href=\"https://seekingalpha.com/symbol/OCSL/dividends?source=news_bullet\">See OCSL Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402652-oaktree-specialty-lending-declares-0_40-dividend",
            "pub_date": "2025-02-04 16:20:30",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402645",
            "title": "Fox Non-GAAP EPS of $0.96 beats by $0.34, revenue of $5.08B beats by $260M",
            "description": "<html><body><ul> <li>Fox <a href=\"https://seekingalpha.com/pr/19990437-fox-reports-second-quarter-fiscal-2025-revenues-of-5_08-billion-net-income-of-388-million-and\">press release</a> (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/FOX\" title=\"Fox Corporation\">FOX</a></span>): Q2 Non-GAAP EPS of $0.96 <span class=\"green\"> beats by $0.34</span>.</li> <li>Revenue of $5.08B (+20.1% Y/Y) <span class=\"green\"> beats by $260M</span>.</li> <li>Quarterly Adjusted EBITDA was $781 million, an increase of $431 million or 123% from the amount reported in the prior year quarter.</li> <li class=\"paywall-full-content invisible\">The company has declared a dividend of $0.27 per Class A and Class B share. This dividend is payable on March 26, 2025 with a record date for determining dividend entitlements of March 5, 2025.</li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402645-fox-non-gaap-eps-of-096-beats-by-034-revenue-of-508b-beats-by-260m",
            "pub_date": "2025-02-04 16:12:27",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402647",
            "title": "Mesa Laboratories Non-GAAP EPS of $2.72 beats by $1.21, revenue of $62.84M beats by $4.01M",
            "description": "<html><body><ul>\n<li>Mesa Laboratories <a href=\"https://seekingalpha.com/pr/19990461-mesa-labs-announces-third-quarter-results\">press release</a>  (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/MLAB\" title=\"Mesa Laboratories, Inc.\">MLAB</a></span>): Q3  Non-GAAP EPS of $2.72 <font color=\"green\"> beats by $1.21</font>.</li>\n<li>Revenue of $62.84M (+17.5% Y/Y) <font color=\"green\"> beats by $4.01M</font>.</li>\n<li>\n<em>Non-GAAP core organic revenues</em><sup>1 </sup><em>increase was 13.2%.</em>\n</li>\n<li>\n<em>Non-GAAP adjusted operating income excluding unusual items</em><sup>2</sup><em> increased 13.3% and was 23.5% as a percentage of revenues.</em>\n</li>\n<li>Total Net Leverage Ratios* as of March 31, 2024, June 30, 2024 and September 30, 2024 were 3.84x, 3.78x, and 3.59x, respectively.</li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402647-mesa-laboratories-non-gaap-eps-of-272-beats-by-121-revenue-of-6284m-beats-by-401m",
            "pub_date": "2025-02-04 16:15:38",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}